Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases

US8999994B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8999994-B2
Application numberUS-201113635894-A
CountryUS
Kind codeB2
Filing dateMar 18, 2011
Priority dateMar 18, 2010
Publication dateApr 7, 2015
Grant dateApr 7, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a compound of formula (I): wherein: R 1 and R 2 are selected from among H and C1-C10 alkyl; R 3 is selected from among H, —OR 4 , N, —CN, —C(O)R 4 , —C(O)OR 4 , —C(O)NR 4 R 5 , —C═NR 4 , —OC(O)R 4 , —NR 4 R 5 , —NR 4 C(O)R 5 , —NO 2 , —N═CR 4 R 5 , halogen and C1-C10 alkyl, wherein R 4 and R 5 are selected from among H, alkyl, alkenyl, cycloalkyl and aryl; X, Y, Z 1 , Z 2 and Z 3 are selected independently from among CH and N; A is selected from among (CH 2 ) n , NH, O and CO, wherein n is an integer between 1 and 6, to the procedure for the obtainment of said compounds, to a pharmaceutical composition comprising said compound, and to the use thereof in the treatment of a neurodegenerative disease, more particularly treatment of Alzheimer's or Parkinson's disease.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) where, R 1 and R 2 are selected from H and C 1 -C 10 alkyl, R 3 is selected from H, —OR 4 , N, —CN, —C(O)R 4 , —C(O)OR 4 , —C(O)NR 4 R 5 , —C═NR 4 , —OC(O)R 4 , —NR 4 R 5 , —NR 4 C(O)R 5 , —NO 2 , —N═CR 4 R 5 , halogen and C 1 -C 10 alkyl, where R 4 and R 5 are selected from H, alkyl, alkenyl, cycloalkyl a…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8999994B2 cover?
The present invention relates to a compound of formula (I): wherein: R 1 and R 2 are selected from among H and C1-C10 alkyl; R 3 is selected from among H, —OR 4 , N, —CN, —C(O)R 4 , —C(O)OR 4 , —C(O)NR 4 R 5 , —C═NR 4 , —OC(O)R 4 , —NR 4 R 5 , —NR 4 C(O)R 5 , —NO 2 , —N═CR 4 R 5 , halogen and C1-C10 a…
Who is the assignee on this patent?
Samadi Abdelouahid, Marco Contelles José Luis, Bolea Tomás Irene, and 5 more
What technology area does this patent fall under?
Primary CPC classification C07D401/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).